The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer

Goring SM,Briggs A,Penrod JR, Fan S, Waser N, Thompson J,Wilson JB,Wang S,Korytowsky B, Chirita O,Hertel N,Yuan Y

VALUE IN HEALTH(2017)

引用 1|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要